Lin Wu

机构：Sun Yat-sen University, Peking University, Sichuan University, Fudan University, National Health and Family Planning Commission, National Clinical Research Center for Digestive Diseases, LC Resources (United States), Chengdu University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Peking University First Hospital, Affiliated Hospital of Jining Medical University, L-3 Communications (United States), Nanjing Medical University, Jinzhou Medical University · ORCID：0000-0001-6737-4646

发表论文 119 篇 · 总被引 1991 次 · h-index 22

代表论文

Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity (2022 · Trends in Pharmacological Sciences · 被引 244)
Empagliflozin attenuates trastuzumab-induced cardiotoxicity through suppression of DNA damage and ferroptosis (2022 · Life Sciences · 被引 61)
Molecular Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity (2024 · JACC Basic to Translational Science · 被引 59)
Targeting DNA damage response in cardiovascular diseases: from pathophysiology to therapeutic implications (2022 · Cardiovascular Research · 被引 57)
Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis (2024 · Redox Biology · 被引 53)
Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy (2023 · Cytokine & Growth Factor Reviews · 被引 41)